Improving Antibiotic Markets for Long-Term Sustainability

Kesselheim AS, Outterson K - Yale Journal of Health Policy, Law and Ethics

  • Innovation Incentives and Competition
  • Regulation and Clinical Evidence

Summary:

The authors examine the challenges facing antibiotic markets, where the unique dynamics of antimicrobial resistance combined with the need for stewardship that limits the volume of new antibiotic prescriptions create commercial disincentives for development that standard market-based approaches fail to address. They propose reforms to improve antibiotic market sustainability through mechanisms that delink revenues from sales volume, ensuring adequate returns for innovative products while preserving their long-term effectiveness through appropriate use.

VIEW SOURCE

Recent Work from PORTAL

Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

International Regulatory Status and Reimbursement Recommendations of Haematological Malignancy Drugs Withdrawn from the FDA Accelerated Approval Pathway

Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy

  • Price, Value, and Access
  • Regulation and Clinical Evidence
Talk bubble graphics representing commentary and opinion.

Politics and the Patient Encounter, in Dire Times

Avorn J - MedPage Today

  • Regulation and Clinical Evidence